| MeSH term | MeSH ID | Detail |
|---|---|---|
| Chemical and Drug Induced Liver Injury | D056486 | 39 associated lipids |
| Pneumonia, Bacterial | D018410 | 16 associated lipids |
| Adenoma, Liver Cell | D018248 | 2 associated lipids |
| Neuroectodermal Tumors, Primitive, Peripheral | D018241 | 3 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Testicular Diseases | D013733 | 15 associated lipids |
| Swine Diseases | D013553 | 16 associated lipids |
| Stomatitis | D013280 | 14 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Spinal Cord Injuries | D013119 | 34 associated lipids |
| Seizures | D012640 | 87 associated lipids |
| Scrapie | D012608 | 7 associated lipids |
| Salmonella Infections, Animal | D012481 | 9 associated lipids |
| Pulmonary Edema | D011654 | 23 associated lipids |
| Pseudorabies | D011557 | 1 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Precancerous Conditions | D011230 | 48 associated lipids |
| Poultry Diseases | D011201 | 21 associated lipids |
| Pasteurella Infections | D010326 | 8 associated lipids |
| Paralysis | D010243 | 4 associated lipids |
fumonisin b1
fumonisin b1 is a lipid of Sphingolipids (SP) class. Fumonisin b1 is associated with abnormalities such as Infection, Kidney Diseases, Liver diseases, DERMATITIS HERPETIFORMIS, FAMILIAL and Malnutrition. The involved functions are known as Gene Expression, Anabolism, Signal, Biosynthetic Pathways and Regulation. Fumonisin b1 often locates in Body tissue, Microsomes, microsomal membrane, Protoplasm and Mitochondria. The associated genes with fumonisin b1 are Genome, P4HTM gene, FATE1 gene, BCL2 gene and TMEM132D gene. The related lipids are dihydroceramide, ceramide 1-phosphate, Sphingolipids, Fatty Acids and Palmitates.
Cross Reference
Introduction
To understand associated biological information of fumonisin b1, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with fumonisin b1?
fumonisin b1 is suspected in Infection, Kidney Diseases, Liver diseases, DERMATITIS HERPETIFORMIS, FAMILIAL, Malnutrition, Celiac Disease and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with fumonisin b1
PubChem Associated disorders and diseases
What pathways are associated with fumonisin b1
Lipid pathways are not clear in current pathway databases. We organized associated pathways with fumonisin b1 through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with fumonisin b1?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with fumonisin b1?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with fumonisin b1?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with fumonisin b1?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with fumonisin b1?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with fumonisin b1
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Enongene EN et al. | Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase. | 2002 | Toxicol. Sci. | pmid:12011476 |
| Mathur S et al. | Fumonisin B(1) increases serum sphinganine concentration but does not alter serum sphingosine concentration or induce cardiovascular changes in milk-fed calves. | 2001 | Toxicol. Sci. | pmid:11248151 |
| Ferrante MC et al. | Effect of fumonisin B1 on structure and function of macrophage plasma membrane. | 2002 | Toxicol. Lett. | pmid:11888701 |
| Bondy GS et al. | Retrospective evaluation of serum ornithine carbamyltransferase activity as an index of hepatotoxicity in toxicological studies with rats. | 2000 | Toxicol. Lett. | pmid:10713481 |
| Raynal M et al. | Effects of fumonisin B1 present in Fusarium moniliforme culture material on drug metabolising enzyme activities in ducks. | 2001 | Toxicol. Lett. | pmid:11369472 |
| Wan LY et al. | Individual and combined effects of Fusarium toxins on the mRNA expression of pro-inflammatory cytokines in swine jejunal epithelial cells. | 2013 | Toxicol. Lett. | pmid:23688591 |
| Steyn PS | Mycotoxins, general view, chemistry and structure. | 1995 | Toxicol. Lett. | pmid:8597152 |
| Kuiper-Goodman T | Mycotoxins: risk assessment and legislation. | 1995 | Toxicol. Lett. | pmid:8597153 |
| Clarke R et al. | High content analysis: a sensitive tool to detect and quantify the cytotoxic, synergistic and antagonistic effects of chemical contaminants in foods. | 2015 | Toxicol. Lett. | pmid:25623391 |
| Chuturgoon AA et al. | Fumonisin Bâ‚ modulates expression of human cytochrome P450 1b1 in human hepatoma (Hepg2) cells by repressing Mir-27b. | 2014 | Toxicol. Lett. | pmid:24614526 |
| Fernández-Blanco C et al. | An in vitro investigation on the cytotoxic and nuclear receptor transcriptional activity of the mycotoxins fumonisin B1 and beauvericin. | 2016 | Toxicol. Lett. | pmid:27234500 |
| Chuturgoon AA et al. | Fumonisin Bâ‚ inhibits apoptosis in HepG2 cells by inducing Birc-8/ILP-2. | 2015 | Toxicol. Lett. | pmid:25800559 |
| Yeung JM et al. | Fumonisin B1 induces protein kinase C translocation via direct interaction with diacylglycerol binding site. | 1996 | Toxicol. Appl. Pharmacol. | pmid:8917690 |
| Martinez-Larrañaga MR et al. | Induction of cytochrome P4501A1 and P4504A1 activities and peroxisomal proliferation by fumonisin B1. | 1996 | Toxicol. Appl. Pharmacol. | pmid:8917691 |
| Howard PC et al. | Comparison of the toxicity of several fumonisin derivatives in a 28-day feeding study with female B6C3F(1) mice. | 2002 | Toxicol. Appl. Pharmacol. | pmid:12498732 |
| Liu BH et al. | The effects of mycotoxins, fumonisin B1 and aflatoxin B1, on primary swine alveolar macrophages. | 2002 | Toxicol. Appl. Pharmacol. | pmid:12009859 |
| Riley RT et al. | Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs. | 1993 | Toxicol. Appl. Pharmacol. | pmid:8430417 |
| Schmelz EM et al. | Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases. | 1998 | Toxicol. Appl. Pharmacol. | pmid:9473533 |
| Norred WP et al. | Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships. | 1997 | Toxicol. Appl. Pharmacol. | pmid:9356308 |
| Gardner NM et al. | Elevated nuclear sphingoid base-1-phosphates and decreased histone deacetylase activity after fumonisin B1 treatment in mouse embryonic fibroblasts. | 2016 | Toxicol. Appl. Pharmacol. | pmid:26905748 |